Fully automated Targeted and Systematic Literature Reviews (SLR)
An automated systematic literature review platform for pharma, biotech, and life sciences. Deployed across Boston, Cambridge, New Jersey, and global markets, it transforms manual review processes into AI-powered, audit-ready evidence generation.
Platform Definition
A flexible, high-accuracy AI solution for SLRs at pharmaceutical scale—supporting FDA submissions, regulatory filings, payer reimbursements, and new therapy evaluations worldwide.
Core Value Proposition
By extracting, synthesizing, and validating medical research, Knolens SLR delivers reliable, up-to-date evidence with full traceability and regulatory audit readiness—powering decisions across the drug development lifecycle.
Design your review, your way — from PICOS to regulatory-ready outputs.
Whether analyzing therapy landscapes, tracking disease progress, assessing biomarkers, or evaluating patient outcomes, it delivers the depth and accuracy needed to drive life sciences forward.